关于质子疗法的相对生物有效性的NRG瘤白皮书
Harald Paganetti1, Charles B Simone2, Walter R Bosch3
1Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts.
概括
本文探讨了质子疗法 (PT) 中的相对生物效应 (RBE),并建议RBE的新临床试验实践,以改进超越当前标准的个性化癌症治疗. 它强调了动态的RBE模型,以获得更好的患者结果.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 生物物理学的生物物理.
背景情况:
- 目前的临床质子疗法 (PT) 使用1.1的标准相对生物效应 (RBE),可能无法完全捕捉生物变异.
- 了解RBE变异对于优化PT疗效和最大限度地减少正常组织毒性至关重要.
- 线性能量转移 (LET) 是影响RBE和生物反应的关键因素.
研究的目的:
- 审查目前对PT中的RBE的理解和临床应用.
- 建议在下一代临床试验中研究和利用RBE的最佳实践.
- 奠定PT个性化生物治疗的基础.
主要方法:
- 审查当前的临床PT实践和RBE的历史背景.
- 对RBE变化的证据分析及其与LET的关系.
- 探索动态RBE模型及其在临床试验中的应用.
- 讨论前性临床试验的方法,以验证RBE优化.
主要成果:
- 有证据表明,PT中的RBE可能会变化,需要超出固定1.1值.
- 动态RBE模型为更准确的治疗规划提供了潜力.
- LET优化可以作为针对特定案例的RBE规划的中间步骤.
结论:
- 下一代PT试验应纳入针对个性化治疗的先进RBE研究.
- 优化RBE需要改进动态模型和通过前性临床试验进行验证.
- 最终目标是针对特定病例的RBE规划,以提高PT的治疗结果.
更多相关视频
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.8K
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.2K
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
